Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Parallel Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in Rescue Treatment of Hypoglycemia in Subjects With Type 1 Diabetes Mellitus Compared to Placebo and With Reference to GlucaGen
Status: Enrolling
Updated:  12/31/1969
ProSciento, Inc.
mi
from
Chula Vista, CA
A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Parallel Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in Rescue Treatment of Hypoglycemia in Subjects With Type 1 Diabetes Mellitus Compared to Placebo and With Reference to GlucaGen
Status: Enrolling
Updated: 12/31/1969
ProSciento, Inc.
mi
from
Chula Vista, CA
Click here to add this to my saved trials
A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Parallel Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in Rescue Treatment of Hypoglycemia in Subjects With Type 1 Diabetes Mellitus Compared to Placebo and With Reference to GlucaGen
Status: Enrolling
Updated:  12/31/1969
Clinical Research Center, Medizinische Universität Graz
mi
from
Graz,
A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Parallel Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in Rescue Treatment of Hypoglycemia in Subjects With Type 1 Diabetes Mellitus Compared to Placebo and With Reference to GlucaGen
Status: Enrolling
Updated: 12/31/1969
Clinical Research Center, Medizinische Universität Graz
mi
from
Graz,
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Birmingham, AL
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Little Rock, AR
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Los Angeles, CA
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Orange, CA
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Centennial, CO
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Centennial, CO
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Jacksonville, FL
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Orlando, FL
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Saint Paul, MN
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Saint Paul, MN
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Jackson, MS
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Jackson, MS
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Lebanon, NH
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Lebanon, NH
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Mineola, NY
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Mineola, NY
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Oklahoma City, OK
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Portland, OR
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Dallas, TX
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Fort Worth, TX
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Tacoma, WA
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated:  12/31/1969
Ascendis Pharma Investigational Site
mi
from
Yerevan,
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Yerevan,
Click here to add this to my saved trials
Effect of Vestibular Stimulation on Fat Consumption and Energy Expenditure as Assessed Using Indirect Calorimetry
Effect of Vestibular Stimulation on Fat Consumption and Energy Expenditure as Assessed Using Indirect Calorimetry
Status: Enrolling
Updated:  12/31/1969
UC San Diego
mi
from
San Diego, CA
Effect of Vestibular Stimulation on Fat Consumption and Energy Expenditure as Assessed Using Indirect Calorimetry
Effect of Vestibular Stimulation on Fat Consumption and Energy Expenditure as Assessed Using Indirect Calorimetry
Status: Enrolling
Updated: 12/31/1969
UC San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Determining Dietary Pattern Accompanying Egg Intake Using Remote Food Photography Method
Determining Dietary Pattern Accompanying Egg Intake Using Remote Food Photography Method
Status: Enrolling
Updated:  12/31/1969
Texas Tech University - Department of Nutritional Sciences
mi
from
Lubbock, TX
Determining Dietary Pattern Accompanying Egg Intake Using Remote Food Photography Method
Determining Dietary Pattern Accompanying Egg Intake Using Remote Food Photography Method
Status: Enrolling
Updated: 12/31/1969
Texas Tech University - Department of Nutritional Sciences
mi
from
Lubbock, TX
Click here to add this to my saved trials
CONFORM: Rotational Fractional Resection for Submental Contouring
The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
Status: Enrolling
Updated:  12/31/1969
Aesthetx
mi
from
Campbell, CA
CONFORM: Rotational Fractional Resection for Submental Contouring
The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
Status: Enrolling
Updated: 12/31/1969
Aesthetx
mi
from
Campbell, CA
Click here to add this to my saved trials
CONFORM: Rotational Fractional Resection for Submental Contouring
The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
Status: Enrolling
Updated:  12/31/1969
Roseville Facial Plastic Surgery
mi
from
Roseville, CA
CONFORM: Rotational Fractional Resection for Submental Contouring
The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
Status: Enrolling
Updated: 12/31/1969
Roseville Facial Plastic Surgery
mi
from
Roseville, CA
Click here to add this to my saved trials
CONFORM: Rotational Fractional Resection for Submental Contouring
The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
Status: Enrolling
Updated:  12/31/1969
DeNova Research
mi
from
Chicago, IL
CONFORM: Rotational Fractional Resection for Submental Contouring
The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
Status: Enrolling
Updated: 12/31/1969
DeNova Research
mi
from
Chicago, IL
Click here to add this to my saved trials
CONFORM: Rotational Fractional Resection for Submental Contouring
The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
Status: Enrolling
Updated:  12/31/1969
Steve Yoelin, MD Medical Associates, INC.
mi
from
Newport Beach, CA
CONFORM: Rotational Fractional Resection for Submental Contouring
The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
Status: Enrolling
Updated: 12/31/1969
Steve Yoelin, MD Medical Associates, INC.
mi
from
Newport Beach, CA
Click here to add this to my saved trials
CONFORM: Rotational Fractional Resection for Submental Contouring
The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
Status: Enrolling
Updated:  12/31/1969
Miami Dermatology & Laser Institute
mi
from
Miami, FL
CONFORM: Rotational Fractional Resection for Submental Contouring
The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
Status: Enrolling
Updated: 12/31/1969
Miami Dermatology & Laser Institute
mi
from
Miami, FL
Click here to add this to my saved trials
CONFORM: Rotational Fractional Resection for Submental Contouring
The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
Status: Enrolling
Updated:  12/31/1969
Sundaram Dermatology, Cosmetic & Laser Surgery Center
mi
from
Fairfax, VA
CONFORM: Rotational Fractional Resection for Submental Contouring
The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
Status: Enrolling
Updated: 12/31/1969
Sundaram Dermatology, Cosmetic & Laser Surgery Center
mi
from
Fairfax, VA
Click here to add this to my saved trials
Racial Differences in Vagal Control of Glucose Homeostasis, Chronic Study
Racial Differences in Vagal Control of Glucose Homeostasis, Chronic Study
Status: Enrolling
Updated:  12/31/1969
Cyndya Shibao
mi
from
Nashville, TN
Racial Differences in Vagal Control of Glucose Homeostasis, Chronic Study
Racial Differences in Vagal Control of Glucose Homeostasis, Chronic Study
Status: Enrolling
Updated: 12/31/1969
Cyndya Shibao
mi
from
Nashville, TN
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Facility in Arkansas
mi
from
Little Rock, AR
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Facility in Arkansas
mi
from
Little Rock, AR
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in California
mi
from
Mission Hills, CA
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in California
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Colorado Springs, Colorado
mi
from
Colorado Springs, CO
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Colorado Springs, Colorado
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Miami, Florida
mi
from
Miami, FL
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Miami, Florida
mi
from
Miami, FL
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in St. Augustine, FL
mi
from
Saint Augustine, FL
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in St. Augustine, FL
mi
from
Saint Augustine, FL
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in New York, New York
mi
from
New York, NY
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in New York, New York
mi
from
New York, NY
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in North Carolina
mi
from
Asheville, NC
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in North Carolina
mi
from
Asheville, NC
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Dothan, Alabama
mi
from
Dothan, AL
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Dothan, Alabama
mi
from
Dothan, AL
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Lauderdale Lakes, FL
mi
from
Lauderdale Lakes, FL
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Lauderdale Lakes, FL
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Maitland, FL
mi
from
Maitland, FL
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Maitland, FL
mi
from
Maitland, FL
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Atlanta, GA
mi
from
Atlanta, GA
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Atlanta, GA
mi
from
Atlanta, GA
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Minneapolis, MN
mi
from
Minneapolis, MN
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Minneapolis, MN
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Greenville, SC
mi
from
Greenville, SC
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Greenville, SC
mi
from
Greenville, SC
Click here to add this to my saved trials
OK432 (Picibanil) in the Treatment of Lymphatic Malformations
OK432 (Picibanil) in the Treatment of Lymphatic Malformations
Status: Enrolling
Updated:  12/31/1969
Richard Smith, MD
mi
from
Iowa City, IA
OK432 (Picibanil) in the Treatment of Lymphatic Malformations
OK432 (Picibanil) in the Treatment of Lymphatic Malformations
Status: Enrolling
Updated: 12/31/1969
Richard Smith, MD
mi
from
Iowa City, IA
Click here to add this to my saved trials
Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC
Assessments of Hybrid Closed Loop and Fully Automated Closed Loop Dose Safety Artificial Pancreas Device in Type 1 Diabetes in a Hospital Clinical Research Setting
Status: Enrolling
Updated:  12/31/1969
Dose Safety
mi
from
Redmond, WA
Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC
Assessments of Hybrid Closed Loop and Fully Automated Closed Loop Dose Safety Artificial Pancreas Device in Type 1 Diabetes in a Hospital Clinical Research Setting
Status: Enrolling
Updated: 12/31/1969
Dose Safety
mi
from
Redmond, WA
Click here to add this to my saved trials
Biomarkers in Exhaled Breath of Glucose Fluctuation in Type 1 Diabetes
Biomarkers in Exhaled Breath of Glucose Fluctuation in Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
Mountain States Health Alliance
mi
from
Johnson City, TN
Biomarkers in Exhaled Breath of Glucose Fluctuation in Type 1 Diabetes
Biomarkers in Exhaled Breath of Glucose Fluctuation in Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Mountain States Health Alliance
mi
from
Johnson City, TN
Click here to add this to my saved trials
G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon (Glucagon for Injection [RDNA Origin]) for Induced Hypoglycemia Rescue in Adults With T1D: a Phase 3 B Multi-Centered, Randomized, Controlled, Single Blind, 2-Way Crossover Study to Evaluate Efficacy and Safety
Status: Enrolling
Updated:  12/31/1969
ProSciento, Inc.
mi
from
Chula Vista, CA
G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon (Glucagon for Injection [RDNA Origin]) for Induced Hypoglycemia Rescue in Adults With T1D: a Phase 3 B Multi-Centered, Randomized, Controlled, Single Blind, 2-Way Crossover Study to Evaluate Efficacy and Safety
Status: Enrolling
Updated: 12/31/1969
ProSciento, Inc.
mi
from
Chula Vista, CA
Click here to add this to my saved trials
G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon (Glucagon for Injection [RDNA Origin]) for Induced Hypoglycemia Rescue in Adults With T1D: a Phase 3 B Multi-Centered, Randomized, Controlled, Single Blind, 2-Way Crossover Study to Evaluate Efficacy and Safety
Status: Enrolling
Updated:  12/31/1969
Diablo Clinical Research Inc
mi
from
Walnut creek, CA
G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon (Glucagon for Injection [RDNA Origin]) for Induced Hypoglycemia Rescue in Adults With T1D: a Phase 3 B Multi-Centered, Randomized, Controlled, Single Blind, 2-Way Crossover Study to Evaluate Efficacy and Safety
Status: Enrolling
Updated: 12/31/1969
Diablo Clinical Research Inc
mi
from
Walnut creek, CA
Click here to add this to my saved trials
G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon (Glucagon for Injection [RDNA Origin]) for Induced Hypoglycemia Rescue in Adults With T1D: a Phase 3 B Multi-Centered, Randomized, Controlled, Single Blind, 2-Way Crossover Study to Evaluate Efficacy and Safety
Status: Enrolling
Updated:  12/31/1969
Atlanta Diabetes Associates
mi
from
Atlanta, GA
G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon (Glucagon for Injection [RDNA Origin]) for Induced Hypoglycemia Rescue in Adults With T1D: a Phase 3 B Multi-Centered, Randomized, Controlled, Single Blind, 2-Way Crossover Study to Evaluate Efficacy and Safety
Status: Enrolling
Updated: 12/31/1969
Atlanta Diabetes Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon (Glucagon for Injection [RDNA Origin]) for Induced Hypoglycemia Rescue in Adults With T1D: a Phase 3 B Multi-Centered, Randomized, Controlled, Single Blind, 2-Way Crossover Study to Evaluate Efficacy and Safety
Status: Enrolling
Updated:  12/31/1969
Rainier Clinical Research Center Inc.
mi
from
Renton, WA
G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon (Glucagon for Injection [RDNA Origin]) for Induced Hypoglycemia Rescue in Adults With T1D: a Phase 3 B Multi-Centered, Randomized, Controlled, Single Blind, 2-Way Crossover Study to Evaluate Efficacy and Safety
Status: Enrolling
Updated: 12/31/1969
Rainier Clinical Research Center Inc.
mi
from
Renton, WA
Click here to add this to my saved trials
G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon (Glucagon for Injection [RDNA Origin]) for Induced Hypoglycemia Rescue in Adults With T1D: a Phase 3 B Multi-Centered, Randomized, Controlled, Single Blind, 2-Way Crossover Study to Evaluate Efficacy and Safety
Status: Enrolling
Updated:  12/31/1969
LMC ESD, Inc.
mi
from
Toronto,
G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon (Glucagon for Injection [RDNA Origin]) for Induced Hypoglycemia Rescue in Adults With T1D: a Phase 3 B Multi-Centered, Randomized, Controlled, Single Blind, 2-Way Crossover Study to Evaluate Efficacy and Safety
Status: Enrolling
Updated: 12/31/1969
LMC ESD, Inc.
mi
from
Toronto,
Click here to add this to my saved trials
Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects
Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects
Status: Enrolling
Updated:  12/31/1969
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects
Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects
Status: Enrolling
Updated: 12/31/1969
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Click here to add this to my saved trials